Diabetes

Glucagon-like peptide-1 receptor agonists have been gaining popularity to treat diabetes. Does this one provide advantages over competitors?

The program launched by the Baltimore-based organizations is the first of its kind to leverage video technology and a public health practice known as Directly Observed Therapy, or DOT.

High-dose intravitreal triamcinolone acetonide deemed a safe and low-cost alternative to anti-vascular endothelial growth factor agents for diabetic macular edema.

Purdue University researchers have developed a shoe insole that could help make the healing process more portable for the 15% of Americans who develop ulcers as a result of diabetes.

Top news of the day from across the health care landscape.

FDA officials cited the possibility of a cardiovascular (CV) safety risk based on Zafgen's prior compound and outlined potential paths for moving forward.

The change aims to reinforce joint product development targets, accelerate the CGM products developer's efforts in type 2 diabetes, and improve its long-term profitability

Top news of the day from across the health care landscape.

The AMA and CDC are working with their local offices, affiliates, and partners to promote and activate the campaign in their communities, with evidence-based materials to aid physicians and other health care providers in the screening, diagnosis and treatment process.

DarioHealth Corp., a leading global digital health company with mobile health and big data solutions, has announced that it has signed an agreement for the rollout of a Digital Diabetes Education and Rewards Program to Giant Eagle's consumers through the pharmacy's 214 locations.

Top news of the day from across the health care landscape

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Officials with the US FDA have approved canagliflozin (Invokana, Janssen) to reduce the risk of major adverse cardiovascular (CV) events, including heart attack, stroke or death due to a cardiovascular cause in adults with type 2 diabetes (T2D) who have established CV disease.

Top news of the day from across the health care landscape.

Insulin education is a key component of diabetes management.

An association between hepatitis C virus infection and incident diabetes found among patients who underwent kidney transplantation.

In spring 2018, the FDA approved the Dexcom G6 CGM System, an integrated continuous glucose monitoring (CGM) system for those with type 1 or type 2 diabetes who are as young as 2 years.

An estimated 1 in 4 patients with diabetes develops foot complications at some point.

As community pharmacists, we are often the most accessible members of the health care team.

Ongoing access to diabetes self-management education and support, and promoting good medication adherence are among the keys to managing high blood glucose in patients with type 2 diabetes.

Survey data reveal rates of diabetes prevalence by subtype among adults.

The first generic drug company in Fayetteville, Arkansas, is opening to provide cost-effective drugs to a community with limited access.

What should these pharmacists do?

Metabolic syndrome involves multiple disease states including hypertension, hyperlipidemia, and possibly diabetes.

A global phase 3a trial successfully demonstrated greater reductions in HbA1c and body weight with a oral semaglutide drug treatment than with dulaglutide, as well as a a comparable number of adverse events in 458 Japanese adults with type 2 diabetes between these medications.

Some researchers propose that vasomotor symptoms may signal physiologic processes that might be associated with other related systemic health diagnoses.

Serious vascular events in patients with diabetes can be prevented with aspirin use, according to results of the ASCEND (A Study of Cardiovascular Events iN Diabetes) trial, which were presented at the ongoing ESC Congress in Munich, Germany.

Serious vascular events in patients with diabetes can be prevented with aspirin use, according to results of the ASCEND (A Study of Cardiovascular Events iN Diabetes) trial, which were presented at the ESC Congress in Munich, Germany.

Higher-than-recommended physical activity levels can help older adults avoid chronic diseases, disability, and cognitive decline for longer.